Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Sutherland

Showing results (551-560 of 613) with videos related to

Pageof 62
Sort By:
Breast Cancer Research : BCR|January 25, 2011
Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancersHuiling Xu, Max Yan, Jennifer Patra, et al.
Cancer Research|July 23, 2003
Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapseSusan M Henshall, Daniel E H Afar, Jordan Hiller, et al.
Cancer Research|March 23, 2005
The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcomeAsne R Bauskin, David A Brown, Simon Junankar, et al.
The Journal of Steroid Biochemistry and Molecular Biology|October 21, 2006
c-Myc overexpression and endocrine resistance in breast cancerCatriona M McNeil, C Marcelo Sergio, Luke R Anderson, et al.
Endocrine-Related Cancer|August 23, 2005
Consensus statement. Workshop on therapeutic resistance in breast cancer: impact of growth factor signalling pathways and implications for future treatmentJ M W Gee, A Howell, W J Gullick, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 25, 2010
Epigenetic deregulation across chromosome 2q14.2 differentiates normal from prostate cancer and provides a regional panel of novel DNA methylation cancer biomarkersJames Devaney, Clare Stirzaker, Wenjia Qu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2018
The Magnitude of Androgen Receptor Positivity in Breast Cancer Is Critical for Reliable Prediction of Disease OutcomeCarmela Ricciardelli, Tina Bianco-Miotto, Shalini Jindal, et al.
British Journal of Cancer|November 23, 2013
Adjuvant chemotherapy in elderly patients with pancreatic cancerA M Nagrial, D K Chang, N Q Nguyen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2012
The prognostic and predictive value of serum CA19.9 in pancreatic cancerJ L Humphris, D K Chang, A L Johns, et al.
Cancer Research|October 16, 2003
E-selectin up-regulation allows for targeted drug delivery in prostate cancerVinay Bhaskar, Debbie A Law, Eric Ibsen, et al.
Pageof 62

Showing results (551-560 of 613) with videos related to

Sort By:
Pageof 62
Breast Cancer Research : BCR|January 25, 2011
Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancersHuiling Xu, Max Yan, Jennifer Patra, et al.
Cancer Research|July 23, 2003
Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapseSusan M Henshall, Daniel E H Afar, Jordan Hiller, et al.
Cancer Research|March 23, 2005
The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcomeAsne R Bauskin, David A Brown, Simon Junankar, et al.
The Journal of Steroid Biochemistry and Molecular Biology|October 21, 2006
c-Myc overexpression and endocrine resistance in breast cancerCatriona M McNeil, C Marcelo Sergio, Luke R Anderson, et al.
Endocrine-Related Cancer|August 23, 2005
Consensus statement. Workshop on therapeutic resistance in breast cancer: impact of growth factor signalling pathways and implications for future treatmentJ M W Gee, A Howell, W J Gullick, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 25, 2010
Epigenetic deregulation across chromosome 2q14.2 differentiates normal from prostate cancer and provides a regional panel of novel DNA methylation cancer biomarkersJames Devaney, Clare Stirzaker, Wenjia Qu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2018
The Magnitude of Androgen Receptor Positivity in Breast Cancer Is Critical for Reliable Prediction of Disease OutcomeCarmela Ricciardelli, Tina Bianco-Miotto, Shalini Jindal, et al.
British Journal of Cancer|November 23, 2013
Adjuvant chemotherapy in elderly patients with pancreatic cancerA M Nagrial, D K Chang, N Q Nguyen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2012
The prognostic and predictive value of serum CA19.9 in pancreatic cancerJ L Humphris, D K Chang, A L Johns, et al.
Cancer Research|October 16, 2003
E-selectin up-regulation allows for targeted drug delivery in prostate cancerVinay Bhaskar, Debbie A Law, Eric Ibsen, et al.
Pageof 62